Table 1 Table summarizing the proportion of estrogen (ER) and progesterone receptor (PR) positive tumor cells, the results from HER2 immunohistochemistry (IHC) and silver in situ hybridization (SISH), the Ki67 proliferation rate as well as histopathological grading of LowHR samples included in this study
Case # | ER (%) | PR (%) | HER2 IHC | HER2 SISH | Ki67 (%) | Grading | cT | cN |
|---|---|---|---|---|---|---|---|---|
1 | 8 | 0 | 1+ | Not done | 80 | G3 | cT2 | cN− |
2 | 5 | 0 | 3+ | Not done | 30 | G3 | cT2 | cN+ |
3 | 2 | 0 | 3+ | Positive | 15 | G2 | cT2 | cN+ |
4 | 5 | 0 | 2+ | Positive | 40 | G3 | cT2 | cN+ |
5 | 5 | 0 | 3+ | Positive | 15 | G2 | cT2 | cN− |
6 | 5 | 0 | 3+ | Positive | 40 | G3 | cT2 | cN− |
7 | 5 | 0 | 3+ | Not done | 30 | G3 | cT2 | cN+ |
8 | 0 | 3 | 1+ | Not done | 90 | G3 | cT1 | cN− |
9 | 5 | 0 | 2+ | Negative | 70 | G3 | cT2 | cN− |
10 | 0 | 5 | 3+ | Not done | 70 | G3 | cT2 | cN− |
11 | 3 | 0 | 0 | Not done | 80 | G3 | cT3 | cN+ |
12 | 5 | 0 | 0 | Not done | 80 | G3 | cT1 | cN+ |
13 | < 1 | 8 | 3+ | Not done | 20 | G3 | cT4 | cN+ |
14 | 5 | 0 | 0 | Not done | 50 | G3 | cT1 | cN+ |
15 | 8 | 8 | 3+ | Not done | 73 | G3 | cT2 | cN+ |
16 | 2 | 0 | 2+ | Negative | 50 | G3 | cT2 | cN− |
17 | 3 | 2 | 2+ | Negative | 85 | G3 | cT1 | cN− |
18 | 3 | < 1 | 3+ | Not done | 40 | G3 | cT2 | cN− |
19 | 3 | 0 | 2+ | Negative | 30 | G3 | cT2 | cN− |
20 | 0 | 5 | 0 | Not done | 95 | G3 | cT2 | cN− |
21 | 2 | 0 | 2+ | Positive | 90 | G3 | cT2 | cN− |
22 | 0 | 5 | 3+ | Not done | 38 | G3 | cT2 | cN− |
23 | 2 | 0 | 3+ | Not done | 35 | G3 | cT2 | cN+ |